Related Experiment Video
Updated: Aug 8, 2026

Avidity-based Extracellular Interaction Screening (AVEXIS) for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
Published on: March 5, 2012
Molecular cloning and binding properties of the human type II activin receptor
C J Donaldson1, L S Mathews, W W Vale
1Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, CA 92037.
Abstract:
A full-length cDNA for the type II human activin receptor was cloned by hybridization from a human testis cDNA library. The sequence encodes a 513 amino acid protein that is 99% identical, at the amino acid level, with the mouse type II activin receptor. The type II human activin receptor consists of an extracellular domain that specifically binds activin A with a Kd of 360 pM, a single-membrane spanning domain, and an intracellular kinase domain with predicted serine/threonine specificity.
Related Concept Videos
RNA Polymerase II Accessory Proteins
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...

